Blog
RSS FeedPosted by Michael Wonder on 24 Jun 2021
TGA grants provisional determination for the Moderna COVID-19 vaccine, Elasomeran
24 June 2021 - Today, the Therapeutic Goods Administration granted provisional determination to Moderna Australia in relation to the COVID-19 ...
Posted by Michael Wonder on 23 Jun 2021
Fees and charges: summary from 1 July 2021
23 June 2021 - The TGA is required to recover its costs for all activities that fall within the scope of ...
Posted by Michael Wonder on 23 Jun 2021
TGA approves first generic pomalidomide
23 June 2021 - The TGA has approved first generic version of Celgene's Pomalyst. ...
Posted by Michael Wonder on 22 Jun 2021
Australia-Canada-Singapore-Switzerland-United Kingdom (Access) Consortium
22 June 2021 - The TGA is a member of the Access consortium along with Health Canada, Health Sciences Authority of ...
Posted by Michael Wonder on 22 Jun 2021
COVID-19 delta strain requires two vaccine doses for protection, Therapeutic Goods Administration boss says
22 June 2021 - Australians will need two doses of a COVID-19 vaccine to adequately protect themselves against the highly ...
Posted by Michael Wonder on 17 Jun 2021
Statement in response to latest ATAGI advice regarding COVID-19 vaccines
17 June 2021 - A statement from the Professor Paul Kelly, Australian Government Chief Medical Officer in response to the latest ...
Posted by Michael Wonder on 17 Jun 2021
COVID-19 vaccine weekly safety report (17 June 2021)
17 June 2021 - Twelve additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...
Posted by Michael Wonder on 10 Jun 2021
COVID-19 vaccine weekly safety report (10 June 2021)
10 June 2021 - Seven additional cases of blood clots with low blood platelets have been assessed as thrombosis with ...
Posted by Michael Wonder on 10 Jun 2021
ATAGI update following weekly COVID-19 meeting – 9 June 2021
10 June 2021 - An update from the Australian Technical Advisory Group on Immunisation following their weekly meeting on 9 June ...
Posted by Michael Wonder on 09 Jun 2021
New Alzheimer’s drug unlikely to be approved in Australia soon, say experts
9 June 2021 - A controversial new drug that has offered hope to Alzheimer’s sufferers by slowing cognitive decline still ...
Posted by Michael Wonder on 09 Jun 2021
Australia tipped to approve Pfizer vaccine for children this year
9 June 2021 - Infectious diseases paediatricians and vaccine experts anticipate the Pfizer shot could be approved for use in ...
Posted by Michael Wonder on 09 Jun 2021
Glaukos Announces Australia’s TGA regulatory approval for Preserflo MicroShunt
8 June 2021 - Glaukos Corporation today announced that the TGA has granted regulatory approval for the Preserflo MicroShunt intended for ...
Posted by Michael Wonder on 07 Jun 2021
Proposed refinements to the regulation of personalised medical devices
7 June 2021 - Regulatory changes introducing a new framework for the regulation of personalised medical devices commenced on 25 ...
Posted by Michael Wonder on 07 Jun 2021
TGA investigating Pfizer jabs for children over 12
7 June 2021 - Australia’s medical regulator is considering allowing children over the age of 12 to be vaccinated with ...
Posted by Michael Wonder on 07 Jun 2021
New regulatory arrangements support businesses and health care professionals to communicate and incentivise COVID-19 vaccination
7 June 2021 - The TGA has implemented arrangements to facilitate the communication of information about approved COVID-19 vaccines. ...